TABLE 2.

Donor patients attributes.

	Age	Sex	Histological diagnosis, tumor grade	Tumor IDH	Tumor localization, lateralization	Epilepsy, type	Anaesthesia
1	56–60	Male	Glioblastoma, 4	Wild type	Parietal, right	Yes, focal	Dexamethasone, Metaoxedrine/Phenylephrine, Prednisolone, Propofol, Remifentanil
2	76–80	Male	Glioblastoma, 4	Wild type	Temporal, right	No	Dexamethasone, Ephedrine, Fentanyl, Metaoxedrine/Phenylephrine, Propofol, Remifentanil
3	70–75	Female	Tissue necrosis	N/A	Temporal, right	No	Dexamethasone,Metaoxedrine/Phenylephrine, Propofol, Remifentanil
4	50–55	Male	Glioblastoma, 4	Wild type	Temporal, right	Yes focal	Dexamethasone,Metaoxedrine/Phenylephrine, Propofol, Remifentanil
5	60–65	Male	Glioblastoma, 4	Wild type	Temporal, left	No	Ephedrine, Metaoxedrine/Phenylephrine, Noradrenalin, Prednisolone, Propofol, Remifentanil
6	60–65	Female	Glioblastoma, 4	Wild type	Occipital, right	Yes, generalized	Dexamethasone, Ephedrine, Fentanyl, Metaoxedrine/Phenylephrine, Noradrenalin, Propofol, Remifentanil
7	70–75	Male	Glioblastoma, 4	Wild type	Temporal, right	No	Ephedrine, Metaoxedrine/Phenylephrine, Prednisolone, Propofol, Remifentanil
8	70–75	Female	Glioblastoma, 4	Wild type	Frontal, left	No	Dexamethasone, Metaoxedrine/Phenylephrine, Ephedrine, Fentanyl, Propofol, Remifentanil
9	60–65	Female	Glioblastoma, 4	Wild type	Parietal, left	No	Dexamethasone, Metaoxedrine/Phenylephrine, Propofol, Remifentanil
10	40–45	Male	Glioblastoma, 4	Wild type	Parietal, left	No	Alfentanil, Dexamethasone, Metaoxedrine/Phenylephrine, Fentanyl, Propofol, Remifentanil, Propofol
11	56–60	Male	Glioblastoma, 4	Wild type	Temporal, left	Yes, generalized	Alfentanil, Dexamethasone, Metaoxedrine/Phenylephrine, Ephedrine, Fentanyl, Propofol, Remifentanil
12	56–60	Male	Glioblastoma, 4	Wild type	Temporal, left	Yes focal	Ephedrine, Fentanyl, Metaoxedrine/Phenylephrine, Propofol, Remifentanil,
13	60–65	Male	Glioblastoma, 4	Wild type	Temporal, right	No	Dexamethasone, Ephedrine, Metaoxedrine/Phenylephrine, Prednisolone, Propofol, Remifentanil
14	70–75	Female	Glioblastoma, 4	Wild type	Temporal, right	No	Dexamethasone, Ephedrine, Fentanyl, Metaoxedrine/Phenylephrine, Propofol, Remifentanil
15	55–60	Male	Glioblastoma, 4	Wild type	Temporal, right	No	Dexamethasone, Ephedrine, Fentanyl, Metaoxedrine/Phenylephrine, Propofol, Remifentanil
16	80–85	Male	Glioblastoma, 4	Wild type	Temporal, right	No	Cefruroxim, Dexamethasone, Ephedrine, Fentanyl, Metaoxedrine/Phenylephrine, Propofol, Remifentanil
17	65–70	Female	Glioblastoma, 4	Wild type	Temporal, right	No	Cefruroxim, Metaoxedrine/Phenylephrine, Propofol, Remifentanil
18	75–80	Female	Gliobastoma, 4	Wild type	Parietal, right	No	Cefruroxim, Ephedrine, Fentanyl, Metaoxedrine/Phenylephrine, Propofol, Remifentanil